What is the market doing?
What the tape says about MDGL
Madrigal Pharmaceuticals, Inc. is +57% over the past year while the S&P 500 is +23%: 35 points ahead of the market.
+57%
1-year return · S&P 500 +23%
- vs 200-day average
- +5.8%
vs 200-day average · close to trend
- RSI (14)
- 60
RSI (14) · neutral
- Below its 52-week high
- −11%
Below its 52-week high
Details›
- Last close2026-08-26
- $538.80
- 1 monthS&P 500 +3.7%
- −0.86%
- 1 yearS&P 500 +23%
- +57%
- 5 yearsS&P 500 +87%
- +513%
- vs 50-day average$513.79
- +4.9%
- 52-week high
- $602.83
- 52-week low
- $345.73
- Annualised volatility
- 53%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- −$4.4M
| Year | Return |
|---|---|
| 2026 (year to date) | −7.5% |
| 2025 | +89% |
| 2024 | +33% |
| 2023 | −20% |
| 2022 | +243% |
| 2021 | −24% |
| 2020 | +22% |
| 2019 | −19% |
| 2018 | +23% |
| 2017 | +516% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 5 of 10 | +1.8% |
| Feb | 10 | 7 of 10 | +6.1% |
| Mar | 10 | 3 of 10 | −1.3% |
| Apr | 10 | 5 of 10 | +0.66% |
| May | 10 | 3 of 10 | +11% |
| Jun | 10 | 7 of 10 | +3.3% |
| Jul | 11 | 2 of 11 | −7.6% |
| Aug | 11 | 7 of 11 | +8.8% |
| Sep | 10 | 4 of 10 | +12% |
| Oct | 10 | 6 of 10 | +5.5% |
| Nov | 10 | 6 of 10 | +9.9% |
| Dec | 10 | 4 of 10 | +37% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.